Study EV-103 cohort L: Evaluating perioperative enfortumab vedotin monotherapy in cis-ineligible muscle invasive bladder cancer (MIBC) (trial in progress) Meeting Abstract


Authors: Hoimes, C. J.; Flaig, T. W.; Srinivas, S.; Mar, N.; Petrylak, D. P.; O'Donnell, P. H.; Bilen, M. A.; Sasse, C.; Yu, Y.; Birrenkott, M.; Rosenberg, J. E.
Abstract Title: Study EV-103 cohort L: Evaluating perioperative enfortumab vedotin monotherapy in cis-ineligible muscle invasive bladder cancer (MIBC) (trial in progress)
Meeting Title: 2022 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 6 Suppl.
Meeting Dates: 2022 Feb 17-19
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-02-20
Language: English
ACCESSION: WOS:000771008900593
DOI: 10.1200/JCO.2022.40.6_suppl.TPS587
PROVIDER: wos
Notes: Meeting Abstract: TPS587 -- Meeting was conducted online as well as in person -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg